Vaccine · BLA
Gardasil 9 NDC 0006-4121
human papillomavirus 9-valent vaccine, recombinant · Human papillomavirus type 6 l1 capsid protein antigen 30 ug/.5mL + 8 more ingredients · Injection, Suspension · Intramuscular · Merck Sharp & Dohme LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0006-4121-02 | 0000641210200006412102 | 10 SYRINGE, GLASS in 1 CARTON (0006-4121-02) / .5 mL in 1 SYRINGE, GLASS (0006-4121-01)Marketed from Dec 10, 2014 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Gardasil 9
- Generic name (nonproprietary)
- human papillomavirus 9-valent vaccine, recombinant
- Active ingredients
- Human papillomavirus type 6 l1 capsid protein antigen — 30 ug/.5mLHuman papillomavirus type 11 l1 capsid protein antigen — 40 ug/.5mLHuman papillomavirus type 16 l1 capsid protein antigen — 60 ug/.5mLHuman papillomavirus type 18 l1 capsid protein antigen — 40 ug/.5mLHuman papillomavirus type 31 l1 capsid protein antigen — 20 ug/.5mLHuman papillomavirus type 33 l1 capsid protein antigen — 20 ug/.5mLHuman papillomavirus type 45 l1 capsid protein antigen — 20 ug/.5mLHuman papillomavirus type 52 l1 capsid protein antigen — 20 ug/.5mLHuman papillomavirus type 58 l1 capsid protein antigen — 20 ug/.5mL
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Labeler
- Merck Sharp & Dohme LLCNDC labeler code 0006
- Product type
- Vaccine
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125508
- Marketing start
- Listing expires
- Other FDA classes
- Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Papillomavirus Vaccines (Chemical structure)Papillomavirus Vaccines (Chemical structure)Papillomavirus Vaccines (Chemical structure)Papillomavirus Vaccines (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)
- Identifiers
- Product ID 0006-4121_318ae380-736e-4519-b865-2f6b443d36baSPL ID 318ae380-736e-4519-b865-2f6b443d36ba
- Pharmacologic class
- Inactivated Human Papillomavirus Vaccine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeMed-Code curated
CPT 90651 — Vaccine product code for GARDASIL 9 (human papillomavirus 9-valent vaccine)
Billing unit: 1 dose. Units on the claim = dose given ÷ 1 dose.
- Administration
Immunization administration (CPT 90460–90474)
Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.
- NDC on a medical claim
N400006412102followed by a unit qualifier and the quantityPackage 00006-4121-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0006-4121
- What is NDC 0006-4121?
- 0006-4121 is the product NDC for Gardasil 9, Human papillomavirus type 6 l1 capsid protein antigen 30 ug/.5mL + 8 more ingredients injection, suspension, listed with the FDA by Merck Sharp & Dohme LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant).
- What is the active ingredient?
- Human papillomavirus type 6 l1 capsid protein antigen, Human papillomavirus type 11 l1 capsid protein antigen, Human papillomavirus type 16 l1 capsid protein antigen, Human papillomavirus type 18 l1 capsid protein antigen, Human papillomavirus type 31 l1 capsid protein antigen, Human papillomavirus type 33 l1 capsid protein antigen, Human papillomavirus type 45 l1 capsid protein antigen, Human papillomavirus type 52 l1 capsid protein antigen, Human papillomavirus type 58 l1 capsid protein antigen.
- Who is the labeler?
- Merck Sharp & Dohme LLC, NDC labeler code 0006. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Gardasil 9?
- 1 other product NDC are listed under this name. See all Gardasil 9 NDCs.
- Is there a related HCPCS / J-code?
- Yes: 90651, Vaccine product code for GARDASIL 9 (human papillomavirus 9-valent vaccine). See Billing references above.
Related NDCs: other Gardasil 9 products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Gardasil 9human papillomavirus 9-valent vaccine, recombinant | Human papillomavirus type 6 l1 capsid protein antigen 30 ug/.5mL + 8 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4119 | 00006-4119-03 |
Other NDCs under BLA 125508
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Gardasil 9human papillomavirus 9-valent vaccine, recombinant | Human papillomavirus type 6 l1 capsid protein antigen 30 ug/.5mL + 8 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4119 |